In-Depth Examination Of 15 Analyst Recommendations For Moderna
In-Depth Examination Of 15 Analyst Recommendations For Moderna
深入研究15位分析師對moderna的建議
In examining recent analyst actions, we gain insights into how financial experts perceive Moderna. The...In the latest quarter, 15 analysts provided ratings for Moderna (NASDAQ:MRNA), showcasing a mix of bullish and bearish perspectives.
在最新季度，有15位分析師爲moderna（納斯達克代碼：MRNA）提供評級，展示了看好和看淡的觀點混合。
Summarizing their recent assessments, the table below illustrates the evolving sentiments in the past 30 days and compares them to the preceding months.
總結他們最近的評估，下表展示了過去30天內不斷變化的情緒，並將其與之前的幾個月進行了比較。
Insights from analysts' 12-month price targets are revealed, presenting an average target of $85.4, a high estimate of $139.00, and a low estimate of $55.00. A decline of 22.58% from the prior average price target is evident in the current average.
分析師的12個月目標價格揭示了一個平均目標價爲$85.4，最高估價爲$139.00，最低估價爲$55.00。當前平均價格顯示與先前平均價格目標相比下降了22.58%。
Breaking Down Analyst Ratings: A Detailed Examination
分析師評級分析：詳細分析
In examining recent analyst actions, we gain insights into how financial experts perceive Moderna. The...
通過審查最近的分析師行動，我們...
登入免費觀看全文
登入/註冊
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
資訊熱榜
更新時間